Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia

Completed · Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Celecoxib may be effective in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia. PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia.

Key facts

Study ID

NCT00043043

Run by

National Cancer Institute (NCI)

Starts

2003-05-01

Expected to finish

2007-10-01

Last updated by the study team

2013-06-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• National Naval Medical Center — Bethesda, Maryland, United States
• Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.